Rheumatoid arthritis: Evidence for bone loss in premenopausal women

Journal of Rheumatology

Volumn 32, Issue 6, 2005, Pages 1020-1025

  Tourinho, Tatiana Freitas ^a   Stein, Aírton ^a   Castro, José A S ^a   Brenol, João C T ^a  

^a Department of Pharmacology   (Brazil)

Author keywords

Bone mass; Densitometry; Glucocorticoid; Osteoporosis; Rheumatoid arthritis

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; GOLD SALT; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; ANEMIA; ARTICLE; BODY WEIGHT; BONE DENSITY; CONTROLLED STUDY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEMUR; FEMUR NECK; HAND RADIOGRAPHY; HORMONAL THERAPY; HUMAN; JOB PERFORMANCE; LABORATORY TEST; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RISK FACTOR;

ADULT; ARTHRITIS, RHEUMATOID; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; FEMUR; GLUCOCORTICOIDS; HEALTH STATUS; HUMANS; LUMBAR VERTEBRAE; PREMENOPAUSE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 20444485276     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Kelley W. Textbook of rheumatology. Philadelphia: W.B. Saunders Company; 1997:851.
2. Allebeck P. Increased mortality in rheumatoid arthritis. Scand J Rheumatol 1982;11:81-6.
3. Bellamy N. Prognosis in rheumatoid arthritis. J Rheumatol 1991;18:1277-9.
4. Capell HA, Murphy EA, Hunter JA. Rheumatoid arthritis: workload and outcome over 10 years. Q J Med 1991;79:461-76.
5. Fries JF. Toward an understanding of patient outcome measurement. Arthritis Rheum 1983;26:697-704.
6. Gordon DA, JL Stein, Broder I. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. Am J Med 1973;54:445-52.
7. Lehtinen K, Isomaki H. Intramuscular gold therapy is associated with long survival in patients with rheumatoid arthritis. J Rheumatol 1991;18:524-9.
8. Pincus T, Callahan LF. Reassessment of twelve traditional paradigms concerning the diagnosis, prevalence, morbidity and mortality of rheumatoid arthritis. Scand J Rheumatol Suppl 1989;79:67-96.
9. Scott DL, Symmons DP, Coulton BL, Popert AJ. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1987;1:1108-11.
10. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
11. Goldring SR, Gravallese EM. Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res 2000;2:33-7.
12. Njeh CF, Genant HK. Bone loss. Quantitative imaging techniques for assessing bone mass in rheumatoid arthritis. Arthritis Res 2000;2:446-50.
13. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
14. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Tourinho TF. Prevenção da osteoporose. In: Brandão ABM, editor. Medicina interna. Rio de Janeiro: Revinter; 1998:277-84.
16. Telama R, Viikari J, Valimaki I, et al. Atherosclerosis precursors in Finnish children and adolescents. X. Leisure-time physical activity. Acta Paediatr Scand Suppl 1985;318:169-80.
17. Wilson PW, Paffenbarger RS, Morris JN, Havlik RJ. Assessment methods for physical activity and physical fitness in population studies: report of a NHLBI workshop. Am Heart J 1986;111:1177-92.
18. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978;118:1-120.
19. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
20. Kaye JJ. Radiographic assessment of rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:395-406.
21. Smolen JS, Breedveld FC, Eberl G, et al. Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 1995;38:38-43.
22. Harris ED Jr. In: Rheumatoid arthritis. Philadelphia: W.B. Saunders Company; 1997:24, 271-278, 281, 307.
23. Genam HK, Engelke K, Fuerst T, et al. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 1996;11:707-30.
24. Bikle DD. Biochemical markers in the assessment of bone disease. Am J Med 1997;103:427-36.
25. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994;4:368-81.
26. Luckey MM. Evaluation of postmenopausal osteoporosis. In: Favus MJ, Christakos S, Kleerekoper M, et al, editors. Primer on the metabolic bone diseases and disorders of mineral metabolism. Philadelphia: Lippincott Williams & Wilkins; 1999:273-7.
27. Star VL, Hochberg MC. Osteoporosis in patients with rheumatic diseases. Rheum Dis Clin North Am 1994;20:561-76.
28. Lindsay R, Cosman F. Prevention of osteoporosis. In: Favus MJ, Christakos S, Kleerekoper M, et al, editors. Primer on the metabolic bone diseases and disorders of mineral metabolism. Philadelphia: Lippincott Williams & Wilkins; 1999:264-70.
29. Forsblad D'Elia H, Larsen A, Waltbrand E, et al. Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis. Ann Rheum Dis 2003;62:617-23.
30. Roux S, Orcel P. Bone loss. Factors that regulate osteoclast differentiation: an update. Arthritis Res 2000;2:451-6.
31. Cortet B, Flipo RM, Blanckaert F, Duquesnoy B, Marchandise X, Delcambre B. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy. Rev Rhum Engl Ed 1997;64:451-8.
32. Hall GM, Spector TD, Griffin AJ, Jawad AS, Hall ML, Doyle DV. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum 1993;36:1510-6.
33. Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S. Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 1987;30:721-8.
34. Sinigaglia L, Nervetti A, Mela Q, et al. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol 2000;27:2582-9.
35. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:993-1000.
36. Minaur NJ, Kounali D, Vedi S, Compston JE, Beresford JN, Bhalla AK. Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density. Rheumatology Oxford 2002;41:741-9.
37. Minaur NJ, Jefferiss C, Bhalla AK, Beresford JN. Methotrexate in the treatment of rheumatoid arthritis. I. In vitro effects on cells of the osteoblast lineage. Rheumatology Oxford 2002;41:735-40.
38. Cooper C. Osteoporosis in rheumatological practice: questions to be answered. Ann Rheum Dis 1995;54:1-2.
39. Dequeker J, Westhovens R. Low dose corticosteroid associated osteoporosis in rheumatoid arthritis and its prophylaxis and treatment: bones of contention. J Rheumatol 1995;22:1013-9.
40. Deodhar AA, Woolf AD. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 1996;35:309-22.
41. Sambrook PN, Eisman JA, Yeates MG, Pocock NA, Eberl S, Champion GD. Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis 1986;45:950-3.
42. Martin JC, Munro R, Campbell MK, Reid DM. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol 1997;36:43-9.
43. Lane NE, Pressman AR, Star VL, Cummings SR, Nevitt MC. Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1995;10:257-63.
44. Solomon DH, Katz JN, La Tourette AM, Coblyn JS. Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial. Arthritis Rheum 2004;51:383-7.